Literature DB >> 2837189

Direct modulation of insulin receptor protein tyrosine kinase by vanadate and anti-insulin receptor monoclonal antibodies.

R Gherzi1, C Caratti, G Andraghetti, S Bertolini, A Montemurro, G Sesti, R Cordera.   

Abstract

Sodium vanadate activates "in vitro" insulin receptor autophosphorylation and protein tyrosine kinase in a dose-dependent manner. Insulin receptor protein tyrosine kinase is directly activated also by the anti-insulin receptor beta subunit monoclonal antibody 18-44. We previously demonstrated that the anti-insulin receptor monoclonal antibody MA-10 decreases insulin-stimulated receptor protein tyrosine kinase activity "in vitro", without inhibiting insulin receptor binding. In this report we show that insulin receptor protein tyrosine kinase, activated by sodium vanadate or by monoclonal antibody 18-44, is inhibited by MA-10 antibody. These data suggest that insulin receptor protein tyrosine kinase activity can be either activated and inhibited through mechanisms different from insulin binding.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2837189     DOI: 10.1016/s0006-291x(88)80452-2

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

Review 1.  Antibodies directed to the insulin receptor. Clinical aspects and applications to the study of insulin action.

Authors:  R De Pirro; P Borboni; M A Marini; A Montemurro; G Sesti; R Lauro
Journal:  J Endocrinol Invest       Date:  1990-12       Impact factor: 4.256

Review 2.  Effects of vanadyl derivatives on animal models of diabetes.

Authors:  G Cros; J J Mongold; J J Serrano; S Ramanadham; J H McNeill
Journal:  Mol Cell Biochem       Date:  1992-02-12       Impact factor: 3.396

3.  Evidence that human and porcine insulin differently affect the human insulin receptor: studies with monoclonal anti-insulin receptor antibodies.

Authors:  G Sesti; M A Marini; A Montemurro; P Borboni; G Di Cola; A Bertoli; R De Pirro; R Lauro
Journal:  J Endocrinol Invest       Date:  1991-12       Impact factor: 4.256

4.  In vivo effects of vanadate on hepatic glycogen metabolizing and lipogenic enzymes in insulin-dependent and insulin-resistant diabetic animals.

Authors:  R L Khandelwal; S Pugazhenthi
Journal:  Mol Cell Biochem       Date:  1995 Dec 6-20       Impact factor: 3.396

5.  Vanadium salts stimulate mitogen-activated protein (MAP) kinases and ribosomal S6 kinases.

Authors:  S K Pandey; J L Chiasson; A K Srivastava
Journal:  Mol Cell Biochem       Date:  1995 Dec 6-20       Impact factor: 3.396

6.  Stimulation of MAP kinase and S6 kinase by vanadium and selenium in rat adipocytes.

Authors:  Y J Hei; S Farahbakhshian; X Chen; M L Battell; J H McNeill
Journal:  Mol Cell Biochem       Date:  1998-01       Impact factor: 3.396

Review 7.  Vanadium and diabetes.

Authors:  P Poucheret; S Verma; M D Grynpas; J H McNeill
Journal:  Mol Cell Biochem       Date:  1998-11       Impact factor: 3.396

8.  Effects of high sucrose diet on insulin-like effects of vanadate in diabetic rats.

Authors:  S Pugazhenthi; J F Angel; R L Khandelwal
Journal:  Mol Cell Biochem       Date:  1993-05-12       Impact factor: 3.396

9.  Effects of vanadate administration on the high sucrose diet-induced aberrations in normal rats.

Authors:  S Pugazhenthi; J F Angel; R L Khandelwal
Journal:  Mol Cell Biochem       Date:  1993-05-12       Impact factor: 3.396

10.  Oral administration of vanadate to diabetic rats restores liver 6-phosphofructo-2-kinase content and mRNA.

Authors:  M Miralpeix; E Carballo; R Bartrons; K Crepin; L Hue; G G Rousseau
Journal:  Diabetologia       Date:  1992-03       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.